DOUBLE-BLIND PLACEBO-CONTROLLED PHASE-II TRIAL OF DIPHTHERIA-INTERLEUKIN-2 FUSION TOXIN (DAB486IL-2) IN PATIENTS WITH REFRACTORY RHEUMATOID-ARTHRITIS (RA)

被引：0

作者：

MORELAND, LW

SEWELL, KL

SULLIVAN, WF

SHMERLING, RH

PARKER, KC

SWARTZ, WG

WOODWORTH, TG

TRENTHAM, DE

KOOPMAN, WJ

机构：

[1] UNIV ALABAMA,BIRMINGHAM,AL 35294

[2] BETH ISRAEL HOSP,BOSTON,MA 02215

[3] SERAGEN INC,HOPKINTON,MA

来源：

ARTHRITIS AND RHEUMATISM | 1993年 / 36卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S39 / S39

页数：1

共 50 条

[41] A novel human monoclonal antibody against IL-15 (humax-IL15) in patients with active rheumatoid arthritis (RA): Results of a double-blind, placebo-controlled phase I/II trial.
Baslund, B
Tvede, N
Danneskiold-Samsoe, B
Petersen, J
Petersen, LJ
Schuurman, J
de Winkel, JV
Larsson, P
Panayi, G
McInnes, LB
ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S653 - S653
[42] First use of a human monoclonal antibody against IL-15 (HuMax-IL15) in patients with active rheumatoid arthritis (RA): Results of a double-blind, placebo-controlled phase I/II trial
Baslund, B
Tvede, N
Danneskiold-Samsoe, B
Petersen, J
Petersen, LJ
Schuurman, J
Van de Winkel, J
Larsson, P
Panayi, G
McIinnes, IB
ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 66 - 67
[43] Oral type II collagen treatment in early rheumatoid arthritis - A double-blind, placebo-controlled, randomized trial
Sieper, J
Kary, S
Sorensen, H
Alten, R
Eggens, U
Huge, W
Hiepe, F
Kuhne, A
Listing, J
Ulbrich, N
Braun, J
Zink, A
Mitchison, NA
ARTHRITIS AND RHEUMATISM, 1996, 39 (01): : 41 - 51
[44] Treatment of rheumatoid arthritis with oral type II collagen - Results of a multicenter, double-blind, placebo-controlled trial
Barnett, ML
Kremer, JM
St Clair, EW
Clegg, DO
Furst, D
Weisman, M
Fletcher, MJF
Chasan-Taber, S
Finger, E
Morales, A
Le, CH
Trentham, DE
ARTHRITIS AND RHEUMATISM, 1998, 41 (02): : 290 - 297
[45] RECOMBINANT HUMAN GAMMA-INTERFERON (GIFN) IN THE TREATMENT OF RHEUMATOID-ARTHRITIS (RA) - DOUBLE-BLIND PLACEBO-CONTROLLED CROSSOVER STUDY
MACHOLD, KP
SMOLEN, JS
CLINICAL RESEARCH, 1989, 37 (02): : A510 - A510
[46] A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF HUMAN ERYTHROPOIETIN FOR THE TREATMENT OF ANEMIA OF CHRONIC DISEASE IN PATIENTS WITH RHEUMATOID-ARTHRITIS
NORDSTROM, D
LINDROTH, Y
MARSAL, L
HAFSTROM, I
HENRICH, C
RANTAPAADAHLQVIST, S
ENGSTROMLAURENT, A
FYHRQUIST, F
FRIMAN, C
ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 814 - 814
[47] PENICILLAMINE AND HYDROXYCHLOROQUINE IN THE TREATMENT OF SEVERE JUVENILE RHEUMATOID-ARTHRITIS - RESULTS OF THE USA USSR DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
BREWER, EJ
GIANNINI, EH
KUZMINA, N
ALEKSEEV, L
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (20): : 1269 - 1276
[48] Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Phase-II Trial: AdrenoMedullin for Ischemic Stroke Study
Yoshimoto, Takeshi
Saito, Satoshi
Omae, Katsuhiro
Hattori, Yorito
Fukuma, Kazuki
Kitamura, Kazuo
Kakuta, Ryosuke
Kita, Toshihiro
Maruyama, Hirofumi
Yamamoto, Haruko
Ihara, Masafumi
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2021, 30 (06):
[49] Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
Hartemann, Agnes
Bensimon, Gilbert
Payan, Christine A.
Jacqueminet, Sophie
Bourron, Olivier
Nicolas, Nathalie
Fonfrede, Michele
Rosenzwajg, Michelle
Bernard, Claude
Klatzmann, David
LANCET DIABETES & ENDOCRINOLOGY, 2013, 1 (04): : 295 - 305
[50] Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial
Butchart, Joseph
Brook, Laura
Hopkins, Vivienne
Teeling, Jessica
Puentener, Ursula
Culliford, David
Sharples, Richard
Sharif, Saif
McFarlane, Brady
Raybould, Rachel
Thomas, Rhodri
Passmore, Peter
Perry, V. Hugh
Holmes, Clive
NEUROLOGY, 2015, 84 (21) : 2161 - 2168

← 1 2 3 4 5 →